Apogee Therapeutics, Inc. - Common Stock (APGE)

Historical Holders from Q3 2023 to Q3 2025

Symbol
APGE on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
46,121,838
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
59,584,018
Holdings value
$2,367,665,565
% of all portfolios
0.004%
Number of holders
172
Number of buys
85
Number of sells
-89
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apogee Therapeutics, Inc. - Common Stock (APGE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $266,406,847 6,907,100 FMR LLC 30 Jun 2025
Fairmount Funds Management LLC 9.99% $229,515,482 5,776,881 Peter Evan Harwin 10 Oct 2025
WELLINGTON MANAGEMENT GROUP LLP 10.6% +28.8% $188,420,081 +$41,633,847 4,885,146 +28.4% Wellington Management Group LLP 31 Jul 2025
RTW INVESTMENTS, LP 6% $102,463,025 2,712,097 RTW Investments, LP 31 Dec 2024
BlackRock, Inc. 5.5% $109,396,539 2,518,725 BlackRock, Inc. 30 Jun 2025
DRIEHAUS CAPITAL MANAGEMENT LLC 4.68% $85,757,284 2,158,502 DRIEHAUS CAPITAL MANAGEMENT LLC 30 Sep 2025

Institutional Holders of Apogee Therapeutics, Inc. - Common Stock (APGE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 59,584,018 $2,367,665,565 +$56,490,694 $39.73 172
2025 Q2 57,837,483 $2,511,890,310 -$147,322,983 $43.43 180
2025 Q1 61,488,037 $2,301,755,351 +$131,273,115 $37.36 165
2024 Q4 57,873,775 $2,621,627,227 +$63,332,544 $45.3 156
2024 Q3 56,092,373 $3,292,239,932 +$134,148,823 $58.74 137
2024 Q2 54,152,101 $2,130,892,019 -$9,800,456 $39.35 137
2024 Q1 52,915,146 $3,516,219,943 +$778,331,224 $66.45 137
2023 Q4 41,768,396 $1,163,676,392 +$48,111,524 $27.94 85
2023 Q3 40,111,211 $848,653,526 +$848,653,497 $21.3 73